.
Discovery Experimental & Development Inc. (DEDI)
This website was written by:
James Kimball
Please Select A Category
In late 1991 DEDI's new LDC was released through doctors and to the public through Mexico.
The reports started coming in almost immediately, (within 90 days) and they were beyond belief. DEDI chose not to believe many of the reports and had a wait and see attitude.
By mid-1992 the repetitive reports coming in from doctors and individuals that had been using LDC for 8 months were overwhelming and now believable.
Doctors and individuals repetitively reported that LDC was very effective with the following medical afflictions:
As The Years Went On, Other Benefits Showed Up
Adverse Side Effects Noted In 9 Years
Medical doctors, homeopathic doctors and naturopathic doctors reported no adverse side effects in nine years of use. Eldepryl, the FDA's approved version of Selegiline HCL reported deaths in patients using the drug Dilantin with Eldepryl. However, medical doctors reporting to DEDI stated, they were prescribingDilantin for their patients using LDC, without any adverse side effects whatsoever.
DEDI received from individuals, reports of adverse side effects which included, headaches in 3% of LDC users, backache in 1% of LDC users, which lasted 12-36 hours. All doctors attributed these adverse effects to be a placebo effect and not noteworthy. However DEDI kept those records anyway.
Examples of Repetitive Reports
Parkinson's Disease
Many doctors and individuals afflicted with terminal Parkinson's disease reported dramatic improvement in their condition. One Parkinson patient in Hollywood, California, Mrs. Freeman found out about LDC in Mexico in late 1991. Mrs. Freeman was in the final stages of Parkinson's. She was bedridden and needed assistance in turning over in bed. Ms. Freeman at the time, in 1991 had Parkinson Disease for about10years and had declined to being bedridden. She was in her mid 50's at the time.
Ms. Freeman, at her medical specialist's recommendation had tried every medication available for Parkinson's disease, including Eldepryl. Eldepryl, Mrs. Freeman told DEDI; did absolutely nothing to help her.
Ms. Freeman, came across LDC in late 1991 and decided to try it. Within weeks she was out of bed, and within months she was back to almost normal, only having a few tremors. In 1992 Mrs. Freeman flew from California to Wesley Chapel, Florida to thank Kimball for developing LDC and saving her life. Mrs. Freeman also flew from California to Florida to testify for Kimball at Kimball's rigged trial in 2000. Rreview Kimball's Rigged Trial.
Although not all people afflicted with Parkinson's had a great success story as Mrs. Freeman. The trial results over 9 years of people using LDC for Parkinson's Disease had revealed that 25% of people using LDC for terminal Parkinson's received no benefit at all. 50% of people afflicted with Parkinson's stopped degenerating and the disease stopped its progression. The remaining 25% of the people using LDC for Parkinson's had a dramatic recovery very similar to Ms. Freeman.
Doctors, researchers, and scientists came to the conclusion after reviewing the trial reports over the years; that LDC could not work if the Substantia Nigra tissue had degenerated to such an extent that it could not produce any dopamine even when properly stimulated by LDC. That would amount for LDC not working in 25% of the people.
With the 50% not degenerating any further using LDC, it was concluded that the tissue had only degenerated partially, or had been partially damaged somehow, and the LDC stimulated the remaining active tissue to emit enough dopamine to stave off the progression of Parkinson's Disease.
DEDI's research group concluded, that it was obvious in the 25% group that nearly fully recovered from Parkinson's that the Substantia Nigra tissue had not degenerated totally and was just emitting too little dopamine. When that Parkinson's sufferer took LDC it stimulated the tissue to produce enough dopamine to nearly normalize the person suffering and dying from the disease.
Everyone in the research group concluded, that if people were to take LDC when they first were diagnosed with Parkinson's Disease, the disease might not progress at all, while some people afflicted may return to normal quickly.
Kimball, DEDI's President, and all members of the research group knew it would be impossible to advise the public of these facts when the entire FDA and pharmaceutical industry was bent on getting rid of Kimball and DEDI. DEDI had to operate out of Mexico as quietly as possible to avoid the corruptgiants, the FDA and pharmaceutical cartel.
Dramatic Improvement In Quality of Life Reported By Thousands
People that had decided to use LDC over 40 years of age for quality of life improvement and the possibility of life extension, reported remarkable results.
People between the ages of 40 and 65 were consistently reporting the following benefits of LDC: dramatic increase in energy, needed less sleep while sleeping much more soundly, became more active, sex drive increased dramatically, were much more attentive, and far less irritable, while in general they felt much better than they had in a long time.
People between the ages of 65 and 85 had basically the same effects as the people 40 - 65 years of age, however, much more spectacular. People were getting out of wheelchairs. People who had given up their driver licenses were driving again. People suffering from dementia, tremors, and speech problems, were acting normal again. Kimball received hundreds of calls from sons and daughters, essentially saying their mothers and fathers got their life back again.
University of Toronto's Late Trial Results On LDC, Late 1990's
A research team at the University of Toronto (UOT) had been working with Kimball and DEDI since late 1992.
They had discovered the contaminants in the FDA approved drug Eldepryl which was believed to have killed Parkinson's patients. More about Eldepryl and the hidden contaminants is located on the first page of this link under How "Eldepryl" approved by the FDA appeared to kill people.
The UOT research team had been comparing DEDI's LDC product with other similar type products for years. They had tested most all similar products to see if they had the same effects upon patients. They found they did not.
The research team had found that LDC, if administered at 10 MGs, within 24 hours of a person suffering a stroke, with stroke induced paralysis, that the paralysis disappears in 90% of the patients within 30 days using LDC at 10MG daily.
The research team even went one step further in their trial. They did exactly the same trial again with stroke victims, suffering from stroke-induced paralysis; only this time they didn't administer DEDI's LDC until 48 hours after the stroke. This trial revealed that in 50% of the patients; the paralysis disappeared within 60 days using LDC at 10 MGs orally daily.
Freedom Of Choice In Medicine